Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
about
Cardiovascular magnetic resonance in the evaluation of heart failure.Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.Prediction of sudden cardiac death: next steps in pursuit of effective methodology.Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy.Targeted Next-Generation Sequencing Reveals Hot Spots and Doubly Heterozygous Mutations in Chinese Patients with Familial CardiomyopathyThe diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.Cardiac magnetic resonance in myocardial diseaseMyocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.Advances in clinical applications of cardiovascular magnetic resonance imagingT1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophyIdentifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art.Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.Cardiac MRI: a central prognostic tool in myocardial fibrosis.Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy.Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.New Paradigms in Hypertrophic Cardiomyopathy: Insights from Genetics.Myocardial late gadolinium enhancement is associated with raised serum amino-terminal propeptide of type III collagen concentrations in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha tropomyosin gene: mThe Role of Cardiovascular Magnetic Resonance in Sports Cardiology; Current Utility and Future PerspectivesUsefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy
P2860
Q30480205-C0697A77-EE4B-46FE-8BD3-45F7BCD9042DQ33580870-5E120D25-8440-459E-AC45-22ADA7B61559Q34629550-89789262-79C7-4A4F-9E49-9959C9F1B2CDQ35122646-DD89FB5E-E452-420E-9831-9549EFD0236AQ35129942-4C928C6C-7CE2-4C0B-97B5-BAAD0B3225F6Q35829323-46E545AF-DAD0-4A53-95EB-1F14EDF87548Q35845452-F70C7146-822D-4939-9B0D-3D8A5BC1B663Q36498834-6F22E77C-879A-4AE1-9E06-283306146E24Q36931178-0A099BE2-4593-40F1-9686-64173A6C8154Q36971128-F1F4DF1A-1279-4198-9CF5-12D5D2A2A4C3Q37160724-1E3FB4BA-8FA6-4A70-97ED-11A68CDB1BC6Q37248274-B44A553A-0DCF-4271-814A-0B48E290EAB8Q37656294-12D962AA-6E39-4C0C-B713-4F93ADC9E405Q37683177-E600A18F-E603-4841-BDD8-0F98A7DE2374Q38263089-49F61874-73F5-4F89-849D-607B5954159AQ38436996-5113D601-DF74-4D0F-BA73-CE2C9FF90D40Q38841287-41DE545A-E94F-4283-9AB0-8AF418FCC3BFQ39729064-7B3851E5-0160-49A1-A498-214F8610853AQ41836826-49E3416D-F9E7-48E2-A040-0DB035BB90EDQ42830448-B11C1853-2BC4-49CA-A297-8A6E2D0C14D5Q57166458-40E2C0B4-6965-4CFD-BF59-41E066B603B8Q58910153-EFFB3EE2-5BD8-45E7-80CA-F89756A1973D
P2860
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Myocardial late gadolinium enh ...... ed by mutations in troponin I.
@ast
Myocardial late gadolinium enh ...... ed by mutations in troponin I.
@en
type
label
Myocardial late gadolinium enh ...... ed by mutations in troponin I.
@ast
Myocardial late gadolinium enh ...... ed by mutations in troponin I.
@en
prefLabel
Myocardial late gadolinium enh ...... ed by mutations in troponin I.
@ast
Myocardial late gadolinium enh ...... ed by mutations in troponin I.
@en
P2093
P2860
P356
P1433
P1476
Myocardial late gadolinium enh ...... ed by mutations in troponin I.
@en
P2093
Elkington AG
Elliott PM
McKenna WJ
Mogensen J
Pennell DJ
P2860
P304
P356
10.1136/HRT.2004.041384
P407
P577
2005-08-01T00:00:00Z